114 related articles for article (PubMed ID: 7501810)
1. Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma.
Zölzer F; Alberti W; Pelzer T; Lamberti G; Hülskamp FH; Streffer C
Radiother Oncol; 1995 Aug; 36(2):128-32. PubMed ID: 7501810
[TBL] [Abstract][Full Text] [Related]
2. Micronucleus assay in vivo provides significant prognostic information in human cervical carcinoma; the updated analysis.
Widel M; Kolosza Z; Jedruś S; Lukaszczyk B; Raczek-Zwierzycka K; Swierniak A
Int J Radiat Biol; 2001 May; 77(5):631-6. PubMed ID: 11382342
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of hyperploid cells in squamous carcinoma of the uterine cervix treated with radiotherapy.
Court JB; Salman SK; Kerby IJ
Radiother Oncol; 1994 Dec; 33(3):266-8. PubMed ID: 7716268
[TBL] [Abstract][Full Text] [Related]
5. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
6. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
[TBL] [Abstract][Full Text] [Related]
7. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.
Widel M; Jedruś S; Owczarek S; Konopacka M; Lubecka B; Kołosza Z
Br J Cancer; 1999 Jul; 80(10):1599-607. PubMed ID: 10408406
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
[TBL] [Abstract][Full Text] [Related]
9. High dose rate cobalt-60 afterloading intracavitary therapy for cervical carcinoma in Srinagarind hospital - analysis of survival.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2010; 11(6):1469-71. PubMed ID: 21338182
[TBL] [Abstract][Full Text] [Related]
10. [Results of stage III carcinoma of the uterine cervix treated by conformation radiotherapy].
Morita K; Watanabe M; Fuwa N
Gan No Rinsho; 1986 Apr; 32(4):371-8. PubMed ID: 3086598
[TBL] [Abstract][Full Text] [Related]
11. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
12. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
Strang P; Stendahl U; Tribukait B
Ann N Y Acad Sci; 1993 Mar; 677():354-63. PubMed ID: 8494220
[No Abstract] [Full Text] [Related]
14. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
Horn LC; Raptis G; Nenning H
Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
[TBL] [Abstract][Full Text] [Related]
15. Long term results of definitive radiotherapy for cervical carcinoma using four applications of high dose rate afterloading.
Busch M; Meden H; Meibodi F; Dühmke E; Kuhn W
Cancer; 1999 Oct; 86(8):1520-7. PubMed ID: 10526281
[TBL] [Abstract][Full Text] [Related]
16. Predicting response to treatment in human cancers of the uterine cervix: sequential biopsies during external beam radiotherapy.
Durand RE; Aquino-Parsons C
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):555-60. PubMed ID: 14751527
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
18. Retrospective DNA analysis by rapid high resolution cytometry in cases with cervical cancer before and after radiotherapy.
Izutsu T; Kagabu T; Nishiya I; Wied GL
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):909-14. PubMed ID: 3418197
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
20. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
